Formulation Development Outsourcing Market Size, Share, and Analysis, By Service (Pre-formulations and Formulation Development), By Formulation (Oral, Injectable, Topical, and Inhaled), By Application (Oncology, Infectious Diseases, Neurology, Hematology, Respiratory, Cardiovascular, and Dermatology), By End-User (Pharmaceutical Industries, Research and Academic Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
Formulation Development Outsourcing Market Size, Share, and Analysis, By Service (Pre-formulations and Formulation Development), By Formulation (Oral, Injectable, Topical, and Inhaled), By Application (Oncology, Infectious Diseases, Neurology, Hematology, Respiratory, Cardiovascular, and Dermatology), By End-User (Pharmaceutical Industries, Research and Academic Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Formulation Development Outsourcing Market is anticipated t%li%exhibit a Compound Annual Growth Rate (CAGR) of 7% during the forecast span from 2024 t%li%2034. In 2023, the market size was assessed at USD 33.9 billion and is projected t%li%reach USD 71.5 billion by the completion of 2034.
Formulation Development Outsourcing refers t%li%the process of hiring external entities or contract research & development firms t%li%manage the development of pharmaceutical or chemical formulations. This outsourcing method enables businesses t%li%utilize the specific expertise of external partners while developing medicine or product compositions. These outsourcing organizations conduct extensive research t%li%discover the ideal combination of ingredients and formulation, which ensures a product's stability and manufacturability. Additionally, companies that outsource formulation development can simplify processes, decrease expenses, and accelerate the time-to-market for new products. Therefore, outsourcing formulation development allows businesses t%li%focus on their core capabilities while benefiting from expertise knowledge and resources for efficient formulation procedures.
MARKET HIGHLIGHTS
Formulation Development Outsourcing Market is projected t%li%reach USD 71.5 billion over the forecast period, due t%li%the rising complexity of drug formulations, combined with high demand for innovative pharmaceuticals and the adoption of affordable strategies by pharmaceutical and biotechnology firms. There has been a considerable increase in outsourcing cooperation as companies are seeking external expertise t%li%improve their formulation methods. Moreover, the global landscape is defined by an abundance of Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) that provide specialized formulation services. Furthermore, strict regulatory needs and rapid improvements in pharmaceutical tech are contributing t%li%the growth of formulation development outsourcing market. Consequently, the market is expected t%li%rise steadily, owing t%li%continuous focus of the industry on research & development activities.
Formulation Development Outsourcing Market Segments:
Growth Drivers
Growing Demand for Specialized Expertise will Create Growth Opportunities
Increased Focus on R&D Efficiency will Lead t%li%Market Expansion
Restraint
Regulatory and Compliance Issues may Impede Industry Growth
Key Players
PRODUCT OVERVIEW
Formulation Development Outsourcing Market is anticipated t%li%exhibit a Compound Annual Growth Rate (CAGR) of 7% during the forecast span from 2024 t%li%2034. In 2023, the market size was assessed at USD 33.9 billion and is projected t%li%reach USD 71.5 billion by the completion of 2034.
Formulation Development Outsourcing refers t%li%the process of hiring external entities or contract research & development firms t%li%manage the development of pharmaceutical or chemical formulations. This outsourcing method enables businesses t%li%utilize the specific expertise of external partners while developing medicine or product compositions. These outsourcing organizations conduct extensive research t%li%discover the ideal combination of ingredients and formulation, which ensures a product's stability and manufacturability. Additionally, companies that outsource formulation development can simplify processes, decrease expenses, and accelerate the time-to-market for new products. Therefore, outsourcing formulation development allows businesses t%li%focus on their core capabilities while benefiting from expertise knowledge and resources for efficient formulation procedures.
MARKET HIGHLIGHTS
Formulation Development Outsourcing Market is projected t%li%reach USD 71.5 billion over the forecast period, due t%li%the rising complexity of drug formulations, combined with high demand for innovative pharmaceuticals and the adoption of affordable strategies by pharmaceutical and biotechnology firms. There has been a considerable increase in outsourcing cooperation as companies are seeking external expertise t%li%improve their formulation methods. Moreover, the global landscape is defined by an abundance of Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) that provide specialized formulation services. Furthermore, strict regulatory needs and rapid improvements in pharmaceutical tech are contributing t%li%the growth of formulation development outsourcing market. Consequently, the market is expected t%li%rise steadily, owing t%li%continuous focus of the industry on research & development activities.
Formulation Development Outsourcing Market Segments:
- By Service
- Pre-formulations
- Formulation Development
- By Formulation
- Oral
- Injectable
- Topical
- Inhaled
- By Application
- Oncology
- Infectious Diseases
- Neurology
- Hematology
- Respiratory
- Cardiovascular
- Dermatology
- By End-User
- Pharmaceutical Industries
- Research and Academic Institutes
- Others
Growth Drivers
Growing Demand for Specialized Expertise will Create Growth Opportunities
Increased Focus on R&D Efficiency will Lead t%li%Market Expansion
Restraint
Regulatory and Compliance Issues may Impede Industry Growth
Key Players
- Catalent, Inc.
- Lonza Group
- Recipharm AB
- Evonik Industries AG
- Patheon
- Cambrex Corporation
- Jubilant Life Sciences
- Aptuit
- Metrics Contract Services
- AMRI (Albany Molecular Research Inc.)
- Curia
- Charles River Laboratories
- WuXi AppTec
- PPD, Inc.
- Pharmaceutics International, Inc.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1.EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2.Business Trends
1.3. Formulation Development Outsourcing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Formulation Development Outsourcing Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.FORMULATION DEVELOPMENT OUTSOURCING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview on world economy
4.3.Industry ecosystem Channel analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.FORMULATION DEVELOPMENT OUTSOURCING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Service
11.3.1.1. Pre-Formulation
11.3.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Formulation Development
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2.Market Share (%) 2024-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2. By Formulation
11.3.2.1.Oral
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2.Market Share (%) 2024-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Injectable
11.3.2.2.1.By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Topical
11.3.2.3.1.By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Inhaled
11.3.2.4.1.By Value (USD Million) 2024-2034F
11.3.2.4.2. Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.By Application
11.3.3.1.Oncology
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2.Market Share (%) 2024-2034F
11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Infectious Diseases
11.3.3.2.1.By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Neurology
11.3.3.3.1.By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Hematology
11.3.3.4.1.By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.5. Respiratory
11.3.3.5.1.By Value (USD Million) 2024-2034F
11.3.3.5.2. Market Share (%) 2024-2034F
11.3.3.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.6. Cardiovascular
11.3.3.6.1.By Value (USD Million) 2024-2034F
11.3.3.6.2. Market Share (%) 2024-2034F
11.3.3.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.7. Dermatology
11.3.3.7.1.By Value (USD Million) 2024-2034F
11.3.3.7.2. Market Share (%) 2024-2034F
11.3.3.7.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.By End-User
11.3.4.1.Pharmaceutical Industries
11.3.4.1.1. By Value (USD Million) 2024-2034F
11.3.4.1.2.Market Share (%) 2024-2034F
11.3.4.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.4.2. Research and Academic Institutes
11.3.4.2.1.By Value (USD Million) 2024-2034F
11.3.4.2.2. Market Share (%) 2024-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.3. Others
11.3.4.3.1.By Value (USD Million) 2024-2034F
11.3.4.3.2. Market Share (%) 2024-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F
12.NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Service
12.3.2. By Formulation
12.3.3. By Application
12.3.4. By End-User
12.4. Country
12.4.1. United States
12.4.2. Canada
13.EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Service
13.3.2. By Formulation
13.3.3. By Application
13.3.4. By End-User
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Service
14.3.2. By Formulation
14.3.3. By Application
14.3.4. By End-User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Service
15.3.2. By Formulation
15.3.3. By Application
15.3.4. By End-User
15.4.Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Service
16.3.2. By Formulation
16.3.3. By Application
16.3.4. By End-User
16.4.Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Catalent, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Lonza Group
18.3. Recipharm AB
18.4. Evonik Industries AG
18.5. Jubilant Life Sciences
18.6. Patheon
18.7. Cambrex Corporation
18.8. Aptuit
18.9. Metrics Contract Services
18.10.AMRI (Albany Molecular Research Inc.)
18.11.Curia
18.12. Charles River Laboratories
18.13. WuXi AppTec
18.14.PPD, Inc.
18.15. Pharmaceutics International, Inc.
18.16. Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2.Business Trends
1.3. Formulation Development Outsourcing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Formulation Development Outsourcing Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.FORMULATION DEVELOPMENT OUTSOURCING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview on world economy
4.3.Industry ecosystem Channel analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.FORMULATION DEVELOPMENT OUTSOURCING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Service
11.3.1.1. Pre-Formulation
11.3.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Formulation Development
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2.Market Share (%) 2024-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2. By Formulation
11.3.2.1.Oral
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2.Market Share (%) 2024-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Injectable
11.3.2.2.1.By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Topical
11.3.2.3.1.By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Inhaled
11.3.2.4.1.By Value (USD Million) 2024-2034F
11.3.2.4.2. Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.By Application
11.3.3.1.Oncology
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2.Market Share (%) 2024-2034F
11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Infectious Diseases
11.3.3.2.1.By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Neurology
11.3.3.3.1.By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Hematology
11.3.3.4.1.By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.5. Respiratory
11.3.3.5.1.By Value (USD Million) 2024-2034F
11.3.3.5.2. Market Share (%) 2024-2034F
11.3.3.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.6. Cardiovascular
11.3.3.6.1.By Value (USD Million) 2024-2034F
11.3.3.6.2. Market Share (%) 2024-2034F
11.3.3.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.7. Dermatology
11.3.3.7.1.By Value (USD Million) 2024-2034F
11.3.3.7.2. Market Share (%) 2024-2034F
11.3.3.7.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.By End-User
11.3.4.1.Pharmaceutical Industries
11.3.4.1.1. By Value (USD Million) 2024-2034F
11.3.4.1.2.Market Share (%) 2024-2034F
11.3.4.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.4.2. Research and Academic Institutes
11.3.4.2.1.By Value (USD Million) 2024-2034F
11.3.4.2.2. Market Share (%) 2024-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.3. Others
11.3.4.3.1.By Value (USD Million) 2024-2034F
11.3.4.3.2. Market Share (%) 2024-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F
12.NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Service
12.3.2. By Formulation
12.3.3. By Application
12.3.4. By End-User
12.4. Country
12.4.1. United States
12.4.2. Canada
13.EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Service
13.3.2. By Formulation
13.3.3. By Application
13.3.4. By End-User
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Service
14.3.2. By Formulation
14.3.3. By Application
14.3.4. By End-User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Service
15.3.2. By Formulation
15.3.3. By Application
15.3.4. By End-User
15.4.Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE & FORECAST 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Service
16.3.2. By Formulation
16.3.3. By Application
16.3.4. By End-User
16.4.Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Catalent, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Lonza Group
18.3. Recipharm AB
18.4. Evonik Industries AG
18.5. Jubilant Life Sciences
18.6. Patheon
18.7. Cambrex Corporation
18.8. Aptuit
18.9. Metrics Contract Services
18.10.AMRI (Albany Molecular Research Inc.)
18.11.Curia
18.12. Charles River Laboratories
18.13. WuXi AppTec
18.14.PPD, Inc.
18.15. Pharmaceutics International, Inc.
18.16. Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
